Literature DB >> 23892200

Should we revise our approach to 'optimal medical therapy'? The case of chronic heart failure.

Luigi Tavazzi1, Aldo P Maggioni, Jeffrey S Borer.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23892200     DOI： 10.1093/eurheartj/eht279

Source DB:  PubMed          Journal:  Eur Heart J        ISSN： 0195-668X            Impact factor:   29.983


× No keyword cloud information.
  3 in total

Review 1.  Higher medication doses in heart failure?

Authors:  James McCormack; Finlay A McAlister; Michael R Kolber
Journal:  Can Fam Physician       Date:  2017-01       Impact factor: 3.275

Review 2.  Trials of implantable monitoring devices in heart failure: which design is optimal?

Authors:  William T Abraham; Wendy G Stough; Ileana L Piña; Cecilia Linde; Jeffrey S Borer; Gaetano M De Ferrari; Roxana Mehran; Kenneth M Stein; Alphons Vincent; Jay S Yadav; Stefan D Anker; Faiez Zannad
Journal:  Nat Rev Cardiol       Date:  2014-08-12       Impact factor: 32.419

Review 3.  Should MRAs be at the front row in heart failure? A plea for the early use of mineralocorticoid receptor antagonists in medical therapy for heart failure based on clinical experience.

Authors:  Ward A Heggermont; Marc Goethals; Riet Dierckx; Sofie Verstreken; Jozef Bartunek; Marc Vanderheyden
Journal:  Heart Fail Rev       Date:  2016-11       Impact factor: 4.214
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.